Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Echoliv


37 rue Lamartine, 75009 Paris
Email : victor@echoliv.ai

President : Bayet Jules
Director General : Neuillet Victor
Web Site >
Echoliv -Genopole's company Echoliv -Genopole's company

#Health #Diagnostics

  • MedTech
  • Artificial Intelligence
  • Deep Learning
  • Medical device
  • SaaS

Field of Activity


Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.

We are currently developing an AI solution for the early detection of the main liver cancer, hepatocellular carcinoma (HCC).

BACKGROUND

Echoliv a été fondée par : Jules Bayet, ingénieur en machine learning, diplômé de l’École Polytechnique ; Victor Neuillet, serial entrepreneur, diplômé de l’ESCP Business School ; Elsa Angelini, experte en machine learning appliquée à l’imagerie médicale avec un doctorat en imagerie biomédicale, professeure-associée à Télécom Paris, Imperial College London et Columbia.

DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY

Echoliv is involved in the diagnosis of early stage HCC. The objective is to concretely bring a gain in specificity and sensitivity in order to increase the number of diagnoses of sick patients and also to reduce positive tests on non-sick patients.
The Echoliv solution is an artificial intelligence-based medical technology for ultrasound. The algorithms analyse and process the images, and detect traces of HCC if present. Radiologists and X-ray manipulators acquire ultrasound videos as in standard practice and thus receive valuable decision support: the algorithm will provide multi-signal identification.

COLLABORATIONS / HIGHLIGHTS

The Echoliv solution will be based on an architecture and know-how developed and tested during academic research on the classification of liver pathology (and particularly HCC).

COLLABORATIONS SOUGHT

Echoliv is looking for hospital partners in order to acquire more data and test the solution directly in the hands of radiologists and hepatologists.

  • More information

    STRENGTHS:
    Know-how in machine learning applied to liver ultrasound

    INNOVATION ASSETS:
    Development of an AI solution that supports ultrasound screening for the major liver cancer (hepatocellular carcinoma)

Genopole’s Companies

#Health


In same field

PEP-Therapy - Genopole's Company - logo 2021

PEP-Therapy

PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

Discover
Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Discover

bYoRNA

Platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis

Discover
Kyron.Bio - Genopole's Company

Kyron.Bio

Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

Discover
CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover
EndoGene.Bio - Genopole's Company

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover
Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Discover
Ciclix - StrokeHub - Genopole's company

Ciclix

Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.

Discover
DeepTope - Genopole's company

Deeptope

– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Discover
Theranovir - Genopole's Company

Theranovir

Biotechnology, R&D, Drug development, oncology, obesity, infectious diseases

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Discover
Traaser - Genopole's Company

TRaaSer

Software for biomedical data analysis

Discover
Synsight - Genopole's Company

Synsight

Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Discover
Sebia - Genopole's Company

Sebia

Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Discover
Santen - Genopole's Company

Santen

Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.

Discover
Pharnext - Genopole's company

Pharnext SA

Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Généthon - Genopole's Laboratory

Généthon

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

Discover
View all >
Share
With the support from
Région île de France